FDA releases bedaquiline briefing docs

FDA's Anti-Infective Drugs Advisory Committee will discuss on Wednesday whether safety and efficacy data support accelerated approval of Sirturo bedaquiline from Johnson & Johnson

Read the full 248 word article

How to gain access

Continue reading with a
two-week free trial.